GlassScriptPhysician profile
Samuel G Deem
NPI 1700909702
$6,129.81
in general payments reported to CMS, 2019-2025
32 companies · $935 in 2025
The $935 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $949 · 2020: $24.44 · 2021: $372 · 2022: $701 · 2023: $1,947 · 2024: $1,201 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,170 · Travel and Lodging: $766 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,169.80 |
| Travel and Lodging | $766.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $124.99 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,926.18 | 2019-2025 | Da Vinci Surgical System |
| Astellas Pharma US INC | $579.79 | 2019-2025 | Xtandi |
| Boston Scientific Corporation | $560.37 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue, Ams 700 |
| Sumitomo Pharma America, INC. | $477.26 | 2023-2025 | Orgovyx |
| Pfizer INC. | $326.52 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $278.57 | 2024-2025 | Erleada |
| Myovant Sciences INC. | $274.25 | 2021-2022 | |
| Bioprotect Medical, INC. | $227.22 | 2024 | Bioprotect Balloon Implant System |
| Richard Wolf Medical Instruments Corp. | $219.55 | 2019-2022 | |
| Janssen Biotech, INC. | $139.04 | 2022-2023 | |
| Procept Biorobotics Corporation | $129.89 | 2019 | |
| Coloplast Corp | $122.02 | 2022 | |
| Olympus America INC. | $118.24 | 2025 | Itind System |
| E.R. Squibb & Sons, L.L.C. | $115.00 | 2019 | |
| Myriad Genetic Laboratories, INC. | $88.18 | 2023 | Prolaris |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $87.59 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Ethicon US, LLC | $72.51 | 2022-2023 | Prolene |
| Progenics Pharmaceuticals, INC. | $43.97 | 2024-2025 | |
| Axonics, INC. | $42.06 | 2024 | Axonics |
| Edap Technomed INC | $42.02 | 2024-2025 | |
| Urogen Pharma, INC. | $41.41 | 2021 | |
| Abbvie INC. | $37.37 | 2022-2025 | |
| Blue Earth Diagnostics | $27.54 | 2021 | |
| Novartis Pharmaceuticals Corporation | $26.66 | 2025 | |
| Antares Pharma, INC. | $25.23 | 2023 | Tlando, Nocdurna, Xyosted |
| Endo Pharmaceuticals INC. | $24.52 | 2023 | Xiaflex |
| Photocure INC | $23.77 | 2024 | Cysview |
| Conmed Corporation | $19.89 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.72 | 2021 | |
| Ferring Pharmaceuticals INC. | $14.47 | 2024 | Adstiladrin |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Deem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.